Product
Iltamiocel
Aliases
Autologous Muscle-Derived Cells (AMDC)
3 clinical trials
2 indications
Indication
Fecal IncontinenceIndication
urinary incontinenceClinical trial
A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal IncontinenceStatus: Completed, Estimated PCD: 2021-10-27
Clinical trial
A Two-stage, Randomized, Controlled Trial Comparing the Safety and Efficacy of Iltamiocel With Placebo in the Treatment of Female Participants With Chronic Fecal Incontinence and a History of Obstetric Anal Sphincter Injury (DigniFI)Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary IncontinenceStatus: Completed, Estimated PCD: 2019-11-01